BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for SUNESIS PHARMACEUTICALS INC CO:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 6:47 pm Purchase | 2020-12-31 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS | BIOTECHNOLOGY VALUE FUND L P | 1,814,308 9.980% | 1,814,308 (New Position) | Filing |